Загрузка...
Activating transcription factor 2 (ATF2) controls tolfenamic acid-induced ATF3 expression via MAP kinase pathways
Tolfenamic acid (TA) is a non-steroidal anti-inflammatory drug associated with anti-tumorigenic and pro-apoptotic properties in animal and in vitro models of cancer. However, the underlying cellular mechanisms by which TA exerts its effects are only partially understood. Activating transcription fac...
Сохранить в:
| Главные авторы: | , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2010
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2940954/ https://ncbi.nlm.nih.gov/pubmed/20581861 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/onc.2010.251 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|